People who had to get below-the-knee amputations after taking Invokana are filing lawsuits against the drug’s manufacturer, Johnson & Johnson.
More than 950 complaints have been filed in New Jersey, Johnson & Johnson’s headquarters. A federal court created a multi-district litigation to combine the complaints.
The lawsuits are in conjunction with a black box warning label that the FDA required for Invokana in 2017. The label warns diabetics who take the drug of risk of amputation.
Source: Drug Watch